Effect of retinoblastoma tumor suppressor gene expression on chemosensitivity of human osteosarcoma cell lines

Koji Iida1, Tsutomu Nobori, Akihiko Matsumine

  • 1Department of Orthopedic Surgery, Mie University School of Medicine, Edobashi 2-174, Tsu City, Mie Prefecture 514-8507, Japan. n73cfq1p@ztv.ne.jp

Oncology Reports
|October 10, 2003
PubMed

Insights

The RB gene

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The RB gene plays a crucial role in cell cycle regulation.
  • Dysregulation of the RB gene is implicated in various cancers, including osteosarcoma.
  • Understanding RB gene function is vital for developing targeted cancer therapies.

Purpose of the Study:

  • To investigate the impact of RB gene inactivation on the chemosensitivity of human osteosarcoma cell lines.
  • To determine if RB gene status influences response to common chemotherapy drugs.

Main Methods:

  • Utilized four human osteosarcoma cell lines: HOS, MG63 (wild-type RB gene), SaOS-2, and OSrb (lacking active RB gene).
  • Performed MTT assays to assess cell viability and calculate inhibition indices.
  • Conducted growth inhibition assays using doxorubicin, cisplatin, and methotrexate.

Main Results:

  • Osteosarcoma cell lines lacking an active RB gene exhibited increased resistance to methotrexate compared to those with an active RB gene.
  • Chemosensitivity to doxorubicin and cisplatin was also evaluated, with varying responses observed across cell lines.

Conclusions:

  • RB gene status significantly influences osteosarcoma cell response to certain chemotherapeutic agents, particularly methotrexate.
  • Targeting or understanding RB gene function may offer strategies to overcome chemoresistance in osteosarcoma.